CAPLIPOINT - Caplin Point Laboratories

Caplin Point Laboratories

CAPLIPOINT · Pharma > Pharmaceuticals & Drugs · Chairman: C C Paarthipan · MD: Sridhar Ganesan · Listing date: June 23, 2014 · Employees: 1675 · Chennai · http://www.caplinpoint.net

Stock Price vs Company Growth

1.7%

6.5%

17.7%

13.1%

29.4%

14.2%

21.1%

10y

23.2%

all

40.7%

🤔 How to analyze this graph?

Last Traded Price

₹ 2,262 1.7%

2,256

2,991

Company Overview

Sales

2,287 Cr

Growth: 13.4%

Profit after Tax

665 Cr

Growth: 3.8%

Mid Cap

17,194 Cr

P/E: 25.9x

Industry P/E: 32.5x

Fundamentals

Sales (Cr)	₹ 2,287
Growth	13.4%
EBITDA	34.8%
P/S	7.5x
Dividend	0.3%
P/E	25.9x
Book Value	₹ 495
PEG Ratio	2.0x
ROE	19.2%
P/B	4.6x

Shareholding Pattern

Institutions

Promoters

P Vijayalakhsmi

23.64 %

Paarthipan C C

18.73 %

Ashok Gorkey Partheeban

11.96 %

Partheeban Vivek Siddarth

11.9 %

May India Property Private Limited

2.8 %

Others

Iepf

2.46 %

Visalatchi

2.22 %

Suresh Kumar Agarwal

1.32 %

Ashish Kacholia

1.16 %

Llp

0.7 %

Increase Decrease No change

Company Profile Detailed

Caplin Point Laboratories is engaged in manufacture of pharmaceuticals formulations. It is a fast-growing Indian pharmaceutical company with global reach, having a 100% export-oriented business. The company supplies a complete range of finished dosage forms. The company operates on a unique business model which predominantly caters to emerging markets of Latin America and Africa and a growing presence in regulated markets like the USA, Canada, Australia etc.

Belongs to (26 Indices) view more

Investors (50)

partheeb...

ashok.go...

liabilit...

Followers (28)

rohit66

damerla

bhaskar2